This observation has also been demonstrated in RA patients treated with TNF-targeting antibodies including infliximab by showing a great efficacy in improving bone mass as well as alleviating RA symptoms such as joint pain [2,8,9,10,11,15,16]. The gene discussed is TNF; the disease is rheumatoid arthritis.